• Nocodazole and the Logic of Microtubule Perturbation

  2026-08-16

  A translational framework for using Nocodazole as a microtubule polymerization inhibitor to connect microtubule dynamics research, cell cycle regulation assays, pathogen entry studies, and anticancer drug evaluation.

• CTOP for Mechanistic Opioid Pain Research

  2026-08-15

  CTOP is a selective μ-opioid receptor antagonist for separating MOR-dependent signaling from downstream spinal and behavioral effects. This guide translates recent circuit-level findings into practical assay and control strategies for opioid receptor binding studies and pain mechanism research.

• β-Elemene: AMPK Adipogenesis Workflow Guide

  2026-08-14

  Use β-Elemene as a mechanistic probe in adipocyte differentiation, insulin-resistance, lipid-accumulation, and AMPK studies. This guide translates a recent 3T3-L1 workflow into practical dosing, assay-selection, formulation, and troubleshooting decisions while distinguishing metabolic evidence from emerging anticancer and neuroprotective applications.

• Gly-Gly-Phe-Gly (GGFG) for Drug Conjugation

  2026-08-14

  Gly-Gly-Phe-Gly (GGFG) provides a compact, flexible peptide scaffold for controlled drug conjugation, antibody-drug conjugate development, and peptide engineering. This practical guide connects linker selection with assay design, workflow controls, and the ER-stress biology highlighted in a multiple myeloma combination-therapy study.

• Letrozole A1307: Reliable Assay Design

  2026-08-13

  A scenario-based guide to using Letrozole (SKU A1307) in cell viability, proliferation, and endocrine-response assays. It translates the compound’s 11.5 nM aromatase IC50, DMSO solubility, storage requirements, and reversible mechanism into practical experimental decisions.

• CTOP: A μ-Opioid Receptor Antagonist

  2026-08-13

  A translational framework for using CTOP to test μ-opioid receptor causality in opioid-induced mechanical hypersensitivity, tolerance, and brain-to-spinal pain circuits.

• Nicotinamide Riboside Chloride in RGC Models

  2026-08-12

  Nicotinamide Riboside Chloride (NIAGEN) adds a controllable NAD+ metabolism variable to reproducible iPSC-derived retinal ganglion cell workflows. This article shows how to separate lineage-generation effects from metabolic resilience, with practical dosing, controls, and troubleshooting for glaucoma and broader neurodegenerative disease models.

• Mitoxantrone BA2039: Reliable Cell Assays

  2026-08-12

  Learn how Mitoxantrone (SKU BA2039) can support reproducible viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers DMSO formulation, assay controls, dose–response design, ABCG2-mediated resistance, and practical product-selection criteria.

• Biotin (Vitamin B7) for Labeling and STING Assays

  2026-08-11

  Biotin (Vitamin B7) connects metabolic biochemistry with high-sensitivity protein and nucleic-acid detection workflows. This guide shows how to prepare the reagent, avoid chemistry-related artifacts, and adapt biotin-based assays to the emerging shrimp STING antiviral model without overstating what the reference study demonstrated.

• Patient-Derived Gastric Cancer Assembloids

  2026-08-11

  This 2025 study develops a patient-derived gastric cancer assembloid that combines matched tumor organoids with tumor-derived stromal subpopulations. The model captures stromal effects on gene expression and drug sensitivity, offering a more informative framework for resistance analysis and personalized preclinical testing than organoid monocultures alone.

• Mitoxantrone HCl: Designing Mechanistic Assays

  2026-08-10

  Mitoxantrone HCl is more than a DNA topoisomerase II inhibitor: it is a versatile probe for separating DNA damage, receptor destabilization, apoptosis, and immune-cell effects. Learn how to design orthogonal assays that clarify mechanism across cancer and disease models.

• Phosbind Acrylamide for Phosphorylation Analysis

  2026-08-09

  Phosbind Acrylamide enables antibody-free resolution of phosphorylated and non-phosphorylated proteins directly in SDS-PAGE. This workflow is especially useful for testing stress-response signaling, kinase activity, and phosphorylation-dependent mobility changes in targets such as eIF2α.

• Transcription Termination After WEE1 Inhibition

  2026-08-08

  The reference study identifies transcription termination as an active safeguard against replication-associated DNA damage after WEE1 inhibition. Its experiments connect termination-factor loss and transcriptional read-through with S-phase genome instability, while supporting combined targeting of WEE1 and CPSF73 in prostate cancer models.

• IGF2BP1–TUBB4B Signaling in Hepatic Stellate Cells

  2026-08-07

  The reference study identifies IGF2BP1 as an m6A reader that promotes hepatic stellate cell activation by stabilizing TUBB4B mRNA and engaging FAK signaling. Its integrated sequencing re-analysis and molecular validation provide a mechanistic framework for studying epitranscriptomic control of liver fibrosis, while also defining important limits for pharmacological translation.

• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit

  2026-08-07

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit addresses the challenge of resolving low molecular weight proteins and peptides (1–10 kDa) that are not efficiently separated by standard Tris-glycine SDS-PAGE. It is intended strictly for research workflows and is unsuitable for diagnostic or clinical use.

16419 records 1/1095 page Next 12345 下5页 Last page